Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379089 · ClinicalTrials.gov registry record
Neurologic Manifestations of COVID 19 in Children
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 3,568
- Enrollment target
NCT04379089: Completed study, sponsored by University of Pittsburgh.
NCT04379089 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 3,568 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04379089 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 3,568 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a secondary analysis of pre-existing de-identified limited datasets obtained from sites participating in Tier 1 (STUDY20040154: Neurologic Manifestations of COVID 19 in Children) and Tier 2 (STUDY20040278: Neuro COVID - Outcomes). The data will be used to determine the prevalence and severity of neurological symptoms among patients requiring critical care admission for confirmed or suspected novel coronavirus (COVID-19) and to determine the predictors for limitation of care in the study population, as well as, the prognosis of neurologically injured patients admitted to the ICU during the COVID-19 crisis. This study is sponsored by the Pediatric Neurocritical Care Research Group (PNCRG) and sponsored and funded in part by the Neurocritical Care Society.
Primary Outcome
Determine the prevalence of neurological manifestations and association with outcome in children with confirmed or presumed COVID-19 and/or MISC hospitalized between January 2020 and December 2021.
Interventions
- OTHER Observational study only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,568 participants |
| Start Date | 2020-04-29 |
| Est. Completion | 2022-12-31 |
What the finished NCT04379089 record still lists
NCT04379089 is an observational study that tracks outcomes without assigning an intervention. Its 3,568 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Observational study only is the first listed.
NCT04379089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04379089 about?
NCT04379089 is a clinical study titled "Neurologic Manifestations of COVID 19 in Children". The purpose of this study is to perform a secondary analysis of pre-existing de-identified limited datasets obtained from sites participating in Tier 1 (STUDY20040154: Neurologic Manifestations of COVID 19 in Children) and Tier 2 (STUDY20040278: Neuro COVID - Outcomes). The data will be used to dete...
What is the current status of trial NCT04379089?
This trial is currently completed. The enrollment target is 3,568 participants. The study started on 2020-04-29. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04379089?
The interventions under investigation include: Observational study only (OTHER).
Who is sponsoring clinical trial NCT04379089?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06429787 · 3,574 participants
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
- NCT03199651 · 3,584 participants · NA
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI